Back to Research

Organization profile

Synendos Therapeutics

[Confidence Level: High] Synendos Therapeutics is a clinical-stage Swiss biotechnology organization pioneering Selective Endocannabinoid Reuptake Inhibitors (SERIs) to treat neuropsychiatric disorders like GAD and PTSD.26

Basel, SwitzerlandFounded 2019

Overview

[Confidence Level: High] Synendos Therapeutics is a clinical-stage Swiss biotechnology organization pioneering Selective Endocannabinoid Reuptake Inhibitors (SERIs) to treat neuropsychiatric disorders like GAD and PTSD.26

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.